Table 4.

Adverse events during quadruple therapy.

	Patients (%), n = 562
Nausea, vomiting	33 (5.9%)
Loose stool, diarrhea	20 (3.6%)
Abdominal discomfort or pain	14 (3.0%)
Dyspepsia, poor oral intake	12 (2.1%)
Headache, dizziness	11 (2.0%)
Dry mouth	6 (1.1%)
General weakness	6 (1.1%)
Others	10 (1.8%)